ASM INTERNATIONAL N.V. REPORTS SECOND QUARTER 2016 RESULTS

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
ASM INTERNATIONAL N.V. REPORTS SECOND QUARTER 2016 RESULTS

Almere, Netherlands, July 28, 2016 (GLOBE NEWSWIRE) -- ASM International N.V. (Euronext Amsterdam: ASM) today reports its second quarter 2016 operating results (unaudited) in accordance with IFRS.

REPORTING 2016

With the 2015 Q4 earnings release, published on February 23, 2016, ASMI announced that as of January 1, 2016, it will report its financial results in accordance with IFRS. Up until the last reporting regarding 2015, ASMI's primary external and internal reporting has been based on US GAAP. In addition ASMI issued quarterly reconciliations of net earnings and shareholders' equity and (semi) annual financial statements prepared in accordance with International Financial Reporting Standards (IFRS). Following the voluntary delisting from NASDAQ, August 2015, ASMI migrated to IFRS as its only internal and external reporting standard from January 1, 2016 and discontinued the use of US GAAP as of the same date. During 2016 comparable results based on US GAAP will be presented, as from 2017 only results based on IFRS will be reported. The main deviations between IFRS and US GAAP are explained in Annex 2.

FINANCIAL HIGHLIGHTS

As from 2016 ASMI reports its results based on IFRS instead of US GAAP.

  Quarter
EUR million Q2 2015 Q1 2016 Q2 2016
New orders 166.6   163.8   159.1  
Net sales 201.0   142.4   138.7  
Gross profit margin % 45.1 % 43.9 % 43.8 %
Operating result 45.4   18.8   16.7  
Result from investments (excl. Amortization intangible assets resulting from the sale of the 12% stake of ASMPT) 20.0   6.3   16.4  
Amortization intangible assets resulting from the sale of the 12% stake of ASMPT (6.8 ) (6.8 ) (6.7 )
Net earnings 41.8   5.4   35.6  
Normalized net earnings (excl. Amortization intangible assets resulting from the sale of the 12% stake of ASMPT) 48.6   12.2   42.3  
  • Net sales for the second quarter 2016 were €139 million, a decrease of 3% compared to the previous quarter. Year-on-year net sales decreased with 31%.
  • New orders at €159 million were 3% below the Q1 2016 level.
  • Normalized net earnings for the second quarter 2016 increased by €30 million compared to the first quarter 2016. Operating result decreased €2 million. The financing result included €8 million positive effects from currencies compared to €11 million negative effects in the first quarter. The result from investments increased with €10 million.

COMMENT

Commenting on the results, Chuck del Prado, President and Chief Executive Officer of ASM International said: "Both Q2 revenues at €139 million, and order intake at €159 million came in at the high end of our guidance. Gross margin remained stable at around the 44%. Net result in Q2 improved strongly to €42 million mainly due to the strong performance of ASMPT and favorable currency developments on cash holdings in foreign currencies."

OUTLOOK

2015 has shown a strong growth of the single wafer ALD market. We estimate this growth to continue whereby the single wafer ALD equipment market will double in the period 2015-2018/2019. We however expect the single wafer ALD market to show a double digit decline in 2016, caused by a low demand in Memory  which will not be offset by the strong increase in Logic/Foundries. Our single wafer ALD market share is expected to show an increase in 2016. We expect the single wafer ALD market to strongly improve again in 2017.

  • In Memory, the NAND market is shifting from Planar NAND to 3D NAND. This shift will significantly reduce the demand for additional multi patterning-related single wafer ALD capacity. Non-patterning related single wafer ALD demand is expected to gradually increase as soon as next generation 3D NAND is going to ramp into high volume.
  • In Memory, DRAM industry capacity demand was high in 2015 and has declined strongly in 2016. Based on current visibility the demand for new DRAM-related single wafer ALD capacity is believed to recover earliest in the course of 2017.
  • In Logic/Foundry the transition to the 10 nm technology node fuels substantially higher single wafer ALD-equipment demand than the previous nodes.

For Q3 we expect sales between €135-150 million, while we expect an order intake of €100-130 million, both on a currency comparable level. We expect a stronger second half in terms of sales as compared to the first half of 2016.

INTERIM FINANCIAL REPORT

On August 31, 2016 ASM International will publish its Interim Financial report for the six months ended June 30, 2016. This report comprises regulated information within the meaning of articles 1:1 and 5:25d of the Dutch Financial Markets Supervision Act (Wet op het Financieel Toezicht) and includes consolidated condensed interim financial statements prepared in accordance with IAS 34, "Interim Financial Reporting", an interim management board report and a management board responsibility statement. The interim financial report for the six months ended June 30, 2016 will be available online at www.asm.com as from August 31, 2016.

SHARE BUYBACK PROGRAM

October 28, 2015 ASMI announced that its Management Board authorized the repurchase of up to €100 million of the Company's common shares within the 2015-2016 time frame. This buyback program will be executed by intermediaries and will end as soon as the aggregate purchase price of the common shares acquired by ASMI has reached €100 million, but ultimately on November 20, 2016.

On May 25, 2016 the General Meeting of Shareholders authorized ASMI to acquire shares for a period of 18 months. The repurchase program is part of ASMI's commitment to use excess cash for the benefit of its shareholders.

The program started on November 26, 2015. On June 30, 2016, just over 65% of the program was completed at an average share price of €36.37.

About ASM International

ASM International NV, headquartered in Almere, the Netherlands, its subsidiaries and participations design and manufacture equipment and materials used to produce semiconductor devices. ASM International, its subsidiaries and participations provide production solutions for wafer processing (Front-end segment) as well as for assembly & packaging and surface mount technology (Back-end segment) through facilities in the United States, Europe, Japan and Asia. ASM International's common stock trades on the Euronext Amsterdam Stock Exchange (symbol ASM). For more information, visit ASMI's website at www.asm.com .

Cautionary Note Regarding Forward-Looking Statements: All matters discussed in this press release, except for any historical data, are forward-looking statements. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. These include, but are not limited to, economic conditions and trends in the semiconductor industry generally and the timing of the industry cycles specifically, currency fluctuations, corporate transactions, financing and liquidity matters, the success of restructurings, the timing of significant orders, market acceptance of new products, competitive factors, litigation involving intellectual property, shareholders or other issues, commercial and economic disruption due to natural disasters, terrorist activity, armed conflict or political instability, epidemics and other risks indicated in the Company's reports and financial statements. The Company assumes no obligation nor intends to update or revise any forward-looking statements to reflect future developments or circumstances.

ASM International will host an investor conference call and webcast on Friday, July 29, 2016 at 15:00 Continental European Time (9:00 a.m. - US Eastern Time).

The teleconference dial-in numbers are as follows: ·      United States:         +1 646 254 3363 ·      International:           +44 (0)20 3427 1919 ·      The Netherlands:     +31 (0)20 716 8296 ·      Access Code:          485540 A simultaneous audio webcast will be accessible at www.asm.com .

CONTACT

Investor contact:

Victor Bareño T: +31 88 100 8500 E: victor.bareno@asm.com

Media contact:

Ian Bickerton T: +31 625 018 512

Press Release Second Quarter 2016 Results http://hugin.info/132090/R/2031518/755955.pdf

HUG#2031518

Scroll down for more posts ▼

Top 10 Most Recent News Articles

JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 123

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 557

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 550

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 305

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 36

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 28

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 287

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 595

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 422

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 102

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading

Top 5 Most Recently Viewed Articles

X-Bow Systems Appoints Experienced COO to Boost Growth

Updated Category News Views 202

X-Bow Systems Inc. scored a major win back in early 2024, tapping Mike Bender as the new Chief Operating Officer. Now, you gotta know—this guy's got over thirty years under his belt in aerospace and defense, so he's not just some suit walking in off the street. New COO in Charge: What’s His Game Plan? Bender's gonna oversee the company's factories and supply chain...

Continue Reading
UroGen Pharma Q3 Financial Overview: Anticipating UGN-102 Launch

Updated Category News Views 108

UroGen Pharma's Third Quarter Financial Report UroGen Pharma Ltd. (NASDAQ: URGN), a company focused on developing innovative therapies for urothelial and specialty cancers, has recently published their financial outcomes for the third quarter of 2024, along with key updates on their operations. This report is particularly pivotal, as it sets the stage for UroGen's future...

Continue Reading
Understanding Recent Options Trends for Chevron: Key Insights

Updated Category News Views 87

Decoding Chevron's Recent Options Activity Investors are closely watching Chevron as recent options activity reveals significant trends among traders. An analysis of the latest trades indicates a predominantly bearish sentiment, with a total of 16 unusual trades being noted. This movement offers a compelling glimpse into investor expectations and potential future price...

Continue Reading
New Research Highlights Life-Extending Benefits of Quitting Smoking for Cancer Patients

Updated Category News Views 160

Research Highlights Impact of Quitting Smoking on Cancer Survival Recent studies indicate that individuals diagnosed with stage III or IV cancer who stop smoking can enjoy nearly one additional year of life compared to those who continue the habit. This finding underscores the essential role that smoking cessation support plays in cancer care. Significant Findings from...

Continue Reading
De La Rue plc Strategic Dealings Unfolding in the Market

Updated Category News Views 189

Overview of Dealings in De La Rue plc As the market evolves, companies like De La Rue plc are continuously involved in dynamic trading activities that provide essential insights into their operations. These dealings are not only a reflection of market conditions but also signify a company’s strategy to navigate the complexities of financial frameworks. Key Details of...

Continue Reading